Holen Sie sich die Stockscreener-App
120.25
1.73%
-2.1599
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$122.41
Offen:
$122.9
24-Stunden-Volumen:
5.56M
Relative Volume:
0.59
Marktkapitalisierung:
$296.95B
Einnahmen:
$65.51B
Nettoeinkommen (Verlust:
$8.93B
KGV:
33.84
EPS:
3.5532
Netto-Cashflow:
$14.12B
1W Leistung:
+5.30%
1M Leistung:
+7.50%
6M Leistung:
+14.97%
1J Leistung:
+55.05%
1-Tages-Spanne:
$120.17
$123.13
1-Wochen-Bereich:
$112.09
$123.13
52-Wochen-Spanne:
$75.40
$125.14
Merck Co Inc Stock (MRK) Company Profile
Firmenname
Merck Co Inc
Sektor
Telefon
908-740-4000
Adresse
126 EAST LINCOLN AVENUE, RAHWAY, NJ
Compare MRK vs LLY, JNJ, ABBV, AZN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRK
Merck Co Inc
|
120.23 | 302.33B | 65.51B | 8.93B | 14.12B | 3.5532 |
LLY
Lilly Eli Co
|
1,072.55 | 949.70B | 72.25B | 25.28B | 10.37B | 27.78 |
JNJ
Johnson Johnson
|
230.69 | 564.11B | 96.36B | 21.04B | 17.80B | 8.6488 |
ABBV
Abbvie Inc
|
212.61 | 381.10B | 62.82B | 3.60B | 19.98B | 2.0274 |
AZN
Astrazeneca Plc
|
187.28 | 290.06B | 60.48B | 10.40B | 8.05B | 3.3297 |
Merck Co Inc Stock (MRK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-25 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-02-20 | Eingeleitet | Barclays | Overweight |
| 2026-02-13 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-18 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2025-11-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2025-11-13 | Eingeleitet | Scotiabank | Sector Outperform |
| 2025-10-13 | Fortgesetzt | Citigroup | Neutral |
| 2025-09-17 | Herabstufung | Berenberg | Buy → Hold |
| 2025-05-14 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-04-22 | Eingeleitet | Cantor Fitzgerald | Neutral |
| 2025-02-18 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-02-10 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-01-08 | Herabstufung | Truist | Buy → Hold |
| 2024-12-20 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2024-12-10 | Fortgesetzt | BofA Securities | Buy |
| 2024-12-04 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-11-11 | Herabstufung | Daiwa Securities | Buy → Neutral |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-03-11 | Herabstufung | Societe Generale | Hold → Sell |
| 2024-01-04 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Buy |
| 2023-10-27 | Hochstufung | BMO Capital Markets | Market Perform → Outperform |
| 2023-10-20 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-14 | Eingeleitet | HSBC Securities | Hold |
| 2023-04-13 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-03-28 | Herabstufung | Societe Generale | Buy → Hold |
| 2023-03-13 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-03-06 | Eingeleitet | Jefferies | Buy |
| 2023-02-22 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-01-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-10-10 | Hochstufung | Guggenheim | Neutral → Buy |
| 2022-09-14 | Hochstufung | Berenberg | Hold → Buy |
| 2022-07-06 | Hochstufung | Daiwa Securities | Neutral → Buy |
| 2022-06-06 | Fortgesetzt | SVB Leerink | Outperform |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2021-12-17 | Eingeleitet | Goldman | Buy |
| 2021-12-16 | Eingeleitet | Daiwa Securities | Neutral |
| 2021-12-13 | Herabstufung | UBS | Buy → Neutral |
| 2021-12-09 | Eingeleitet | Wells Fargo | Overweight |
| 2021-12-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-11-29 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-11-19 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2021-11-01 | Hochstufung | Argus | Hold → Buy |
| 2021-09-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-05-20 | Herabstufung | Argus | Buy → Hold |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-08-03 | Hochstufung | Goldman | Neutral → Buy |
| 2020-06-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-02-27 | Eingeleitet | Barclays | Overweight |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-10-17 | Fortgesetzt | BofA/Merrill | Neutral |
| 2019-08-16 | Eingeleitet | SVB Leerink | Outperform |
| 2019-07-03 | Eingeleitet | Mizuho | Buy |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-05-13 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2018-10-16 | Bestätigt | Citigroup | Buy |
| 2018-10-09 | Fortgesetzt | Guggenheim | Buy |
| 2018-04-23 | Hochstufung | Goldman | Neutral → Buy |
| 2018-04-17 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2018-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2018-03-12 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-02-14 | Bestätigt | Leerink Partners | Mkt Perform |
| 2018-02-07 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2018-01-16 | Hochstufung | SunTrust | Hold → Buy |
Alle ansehen
Merck Co Inc Aktie (MRK) Neueste Nachrichten
Merck & Co. Inc. stock (US58933Y1055): Key cancer drug momentum after latest Keytruda and Lynparza u - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): 6 billion USD bond deal shifts focus to financing strategy - AD HOC NEWS
3 Dividend Stocks to Hold for the Next 10 Years - The Motley Fool
Merck & Co., Inc. (MRK) Completes $6 Billion Public Offering of Notes - GuruFocus
Legal & General Group Plc Has $2.08 Billion Stock Position in Merck & Co., Inc. $MRK - MarketBeat
Morningstar Investment Management LLC Sells 93,011 Shares of Merck & Co., Inc. $MRK - MarketBeat
RHL Group LLC Makes New Investment in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Holdings Decreased by New Age Alpha Advisors LLC - MarketBeat
Choate Investment Advisors Buys 13,581 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Fisher Asset Management LLC - MarketBeat
Merck & Co., Inc. stock (US58933Y1055): Key takeaways from the latest Keytruda and pipeline updates - AD HOC NEWS
Genus Capital Management Inc. Takes Position in Merck & Co., Inc. $MRK - MarketBeat
Mondrian Investment Partners LTD Sells 38,085 Shares of Merck & Co., Inc. $MRK - MarketBeat
Smead Capital Management Inc. Sells 196,374 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co Inc (MRK) Stock Price, Trades & News - GuruFocus
Catalyst Funds Management Pty Ltd Buys 22,100 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock (US58933Y1055): FDA nod for Winrevair reshapes growth story - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): cancer franchise drives outlook after latest Keytruda data - AD HOC NEWS
Merck (MRK) Phase 3 TroFuse-005 Trial for Endometrial Cancer Meets Primary Endpoints - Yahoo Finance
LSV Asset Management Cuts Stake in Merck & Co., Inc. $MRK - MarketBeat
Legato Capital Management LLC Buys 8,759 Shares of Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. stock (US58933Y1055): oncology momentum and fresh debt deal move MRK - AD HOC NEWS
A Look at Merck & Co Inc (MRK) After 5.6% Gain -- GF Value $118. - GuruFocus
A Look at Merck & Co Inc (MRK) After 5.6% Gain -- GF Value $118.14 vs Price $122.41 - GuruFocus
Research Alert: CFRA Raises Opinion On Shares Of Merck & Co., Inc. To Strong Buy From Buy - Moomoo
US58933YCE3 Bond Price and Chart — FWB:US58933YCE3 - TradingView
AbbVie, Merck, Astra among winners of EU drug recommendations this week - Seeking Alpha
Merck & Co Inc Stock (MRK) Opened Up by 4.50% on May 22: Facts Behind the Movement - TradingKey
Merck & Co., Inc. stock (US58933Y1055): Key cancer drug data and dividend profile in focus - AD HOC NEWS
Merck and Kelun's lung cancer combo bests Keytruda in late-stage trial - Seeking Alpha
Keudell Morrison Wealth Management Invests $1.33 Million in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co., Inc. $MRK Shares Bought by Pinnbrook Capital Management LP - MarketBeat
Axxcess Wealth Management LLC Buys 263,633 Shares of Merck & Co., Inc. $MRK - MarketBeat
MRK News | MERCK & CO. INC. (NYSE:MRK) - ChartMill
MRK Stock Quote Price and Forecast - CNN
Merck and Ecolab lead M&A funding charge - GlobalCapital
Moderna, Merck cancer combo cuts melanoma spread risk at five years - Reuters
All Merck Articles - 24/7 Wall St.
Merck & Co., Inc. Balance Sheet – BVL:MRKUS - TradingView
44 WEALTH MANAGEMENT LLC's Merck & Co Inc(MRK) Holding History - GuruFocus
Merck & Co. Inc. stock (US58933Y1055): Keytruda data and Q1 2026 results keep pharma heavyweight in - AD HOC NEWS
Merck & Co. Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Merck & Co. Inc. stock (US58933Y1055): Key takeaways from the latest Keytruda growth and pipeline up - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Key takeaways after latest Keytruda data and Q1 earnings - AD HOC NEWS
MRK6400123 Bond Price and Chart — FINRA:MRK6400123 - TradingView
Cullen Frost Bankers Inc. Has $22.74 Million Position in Merck & Co., Inc. $MRK - MarketBeat
Merck & Co. Inc. stock (US58933Y1055): Key takeaways after latest Keytruda data and oncology updates - AD HOC NEWS
Merck & Co., Inc. stock (US58933Y1055): Key takeaways after the latest Keytruda and Gardasil updates - AD HOC NEWS
VANGUARD ADVICE SELECT GLOBAL VALUE FUND's Merck & Co Inc(MRK) Holding History - GuruFocus
Handelsbanken Fonder AB Boosts Stock Holdings in Merck & Co., Inc. $MRK - MarketBeat
Gabelli Funds LLC Cuts Holdings in Merck & Co., Inc. $MRK - MarketBeat
Finanzdaten der Merck Co Inc-Aktie (MRK)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.77%
0.66%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):